查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1772231

美國過敏診斷與治療市場：市場規模、佔有率、趨勢分析（按類型、過敏原類型和測試類型）、細分市場預測（2025-2030 年）

U.S. Allergy Diagnostics & Therapeutics Market Size, Share & Trends Analysis Report By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled, Drug, & Other Allergens), By Test Type, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

美國過敏診斷和治療市場規模預計在2024年達到108.6億美元，2025年至2030年的複合年成長率為6.8%。推動這一市場發展的因素包括人群中過敏症盛行率的不斷上升，以及污染加劇和生活方式改變等環境因素對先進解決方案的需求。美國過敏診斷和治療產業正經歷著向精準診斷的轉變。這項轉變的動力源自於分子過敏學的突破性創新以及數位健康工具的廣泛應用。

各公司正積極擴展其過敏檢測產品組合，並專注於能夠同時從單一檢體中檢測多種過敏原的多重檢測。此外，這些診斷平台擴大被設計為與電子健康記錄(EHR) 無縫整合，這是促進全面患者資料管理和增強臨床決策的關鍵進步。

該行業的特點是高度創新，這得益於持續的研發、技術進步以及更有效的診斷和治療方法的開發。 2025年4月，貝克曼庫爾特生命科學部宣布推出其下一代嗜鹼性粒細胞活化測試（BAT），僅用於研究目的，以加速和改進過敏研究。

美國過敏診斷和治療行業的特點是，大量新產品的推出、策略聯盟的建立以及主要企業之間的收購，重點在於提高診斷的準確性和治療效果。 2024年1月，Inimmune Corporation 和 Intrommune Therapeutics 宣佈建立策略聯盟，共同開發突破性的花生過敏口腔黏膜免疫療法。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章美國過敏診斷與治療市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 美國過敏診斷與治療市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析
  • 美國過敏診斷與治療市場：管道分析

第4章美國過敏診斷和治療市場：按類型估計和趨勢分析

  • 細分儀表板：按類型
  • 美國過敏診斷與治療市場：按類型變化分析
  • 美國過敏診斷及治療市場規模及趨勢分析（2018-2030）
  • 診斷
    • 裝置
    • 耗材
    • 服務
  • 治療
    • 抗組織胺藥
    • 鼻減充血劑
    • 皮質類固醇
    • 肥大細胞穩定劑
    • 白三烯抑制劑
    • 鼻用抗膽鹼藥物
    • 免疫調節劑
    • 腎上腺素
    • 免疫療法

第5章美國過敏診斷和治療市場：按過敏原類型進行的估計和趨勢分析

  • 細分儀表板：依過敏原類型
  • 美國過敏診斷與治療市場：按過敏原類型變化分析
  • 美國過敏診斷及治療市場規模及過敏原類型趨勢分析（2018-2030）
  • 食物
    • 乳製品
    • 家禽產品
    • 堅果
    • 花生
    • 貝類
    • 小麥
    • 大豆
    • 其他食物過敏原
  • 吸入
  • 藥物
  • 其他過敏原

第6章美國過敏診斷和治療市場：按測試類型進行的估計和趨勢分析

  • 細分儀表板：依測試類型
  • 美國過敏診斷與治療市場：按測試類型變化分析
  • 美國過敏診斷及治療市場規模及趨勢分析（依檢驗類型）（2018-2030）
  • 體內測試
    • 皮膚點刺試驗
    • 皮內試驗
    • 斑貼試驗
  • 體外測試

第7章 競爭態勢

  • 主要企業近期趨勢及影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要企業熱力圖分析（2024年）
  • 公司簡介
    • Thermo Fischer Scientific Inc.
    • Stallergenes Greer
    • HYCOR Biomedical
    • Minaris Medical America, Inc.
    • Omega Diagnostics Ltd
    • Lincoln Diagnostics, Inc.
    • Danaher Corporation
    • Alcon Inc.
    • AbbVie Inc.
    • Sanofi
    • Pfizer Inc.
    • Merck &Co., Inc.
Product Code: GVR-4-68040-650-0

Market Size & Trends:

The U.S. allergy diagnostics & therapeutics market size was valued at USD 10.86 billion in 2024 and is projected to grow at a CAGR of 6.8% from 2025 to 2030. The market is driven by the increasing prevalence of allergies among the population, and environmental factors such as increased pollution and lifestyle changes boost the demand for advanced solutions. The U.S. allergy diagnostics & therapeutics industry has witnessed a shift toward precision diagnostics. This evolution is fueled by groundbreaking innovations in molecular allergology and the widespread adoption of digital health tools.

Companies are actively expanding their allergy test portfolios, focusing on multiplex assays that enable the simultaneous detection of numerous allergens from a single patient sample. Furthermore, these diagnostic platforms are increasingly designed for seamless integration with Electronic Health Records (EHRs), a critical advancement that facilitates comprehensive patient data management and enhances clinical decision-making.

The industry is characterized by a high degree of innovation driven by ongoing research, technological advancements, and the development of more effective diagnostics and treatment options. In April 2025, Beckman Coulter Life Sciences announced the launch of its Next-Generation Basophil Activation Test (BAT). It is only for research purposes to expedite and improve allergy research.

The U.S. allergy diagnostics & therapeutics industry is also characterized by many new launches, strategic collaborations, and acquisitions among key players, emphasizing enhancing diagnostic accuracy and therapeutic efficacy. In January 2024, Inimmune Corporation and Intrommune Therapeutics announced a strategic partnership to develop a groundbreaking oral mucosal immunotherapy for peanut allergy.

U.S. Allergy Diagnostics & Therapeutics Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. allergy diagnostics & therapeutics market report based on type, allergen type, test type.

  • Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Diagnostics
    • Instruments
    • Consumables
    • Services
  • Therapeutics
    • Antihistamines
    • Decongestants
    • Corticosteroids
    • Mast Cell Stabilizers
    • Leukotriene Inhibitors
    • Nasal Anti-cholinergic
    • Immuno-modulators
    • Epinephrine
    • Immunotherapy
  • Allergen Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Food
    • Dairy Products
    • Poultry Product
    • Tree Nuts
    • Peanuts
    • Shellfish
    • Wheat
    • Soys
    • Other Food Allergens
  • Inhaled
  • Drug
  • Other Allergens
  • Test Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • In vivo test
    • Skin Prick Test
    • Intradermal Test
    • Patch Test
  • In vitro test

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Allergen Type
    • 1.2.3. Test Type
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test outlook
    • 2.2.2. Allergen Type outlook
    • 2.2.3. Test Type outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Allergy Diagnostics & Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Allergy Diagnostics & Therapeutics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. U.S. Allergy Diagnostics & Therapeutics Market: Pipeline Analysis

Chapter 4. U.S. Allergy Diagnostics & Therapeutics Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. U.S. Allergy Diagnostics & Therapeutics Market: Type Movement Analysis
  • 4.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, By Type, 2018 To 2030 (USD Billion)
  • 4.4. Diagnostics
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Instruments
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.3. Consumables
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.4. Services
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Therapeutics
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2. Antihistamines
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.3. Decongestants
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.4. Corticosteroids
      • 4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.5. Mast Cell Stabilizers
      • 4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.6. Leukotriene Inhibitors
      • 4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.7. Nasal Anti - Cholinergic
      • 4.5.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.8. Immuno - Modulators
      • 4.5.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.9. Epinephrine
      • 4.5.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.10. Immunotherapy
      • 4.5.10.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. U.S. Allergy Diagnostics & Therapeutics Market: Allergen Type Estimates & Trend Analysis

  • 5.1. Allergen Type Segment Dashboard
  • 5.2. U.S. Allergy Diagnostics & Therapeutics Market: Allergen Type Movement Analysis
  • 5.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, by Allergen Type, 2018 to 2030 (USD Billion)
  • 5.4. Food
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.2. Dairy Products
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.3. Poultry Product
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.4. Tree Nuts
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.5. Peanuts
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.6. Shellfish
      • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.7. Wheat
      • 5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.8. Soys
      • 5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.9. Other Food Allergens
      • 5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Inhaled
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Drug
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7. Other Allergens
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. U.S. Allergy Diagnostics & Therapeutics Market: Test Type Estimates & Trend Analysis

  • 6.1. Test Type Segment Dashboard
  • 6.2. U.S. Allergy Diagnostics & Therapeutics Market: Test Type Movement Analysis
  • 6.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, By Test Type, 2018 to 2030 (USD Billion)
  • 6.4. In vivo test
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 6.4.2. Skin Prick Test
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 6.4.3. Intradermal Test
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 6.4.4. Patch Test
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. In vitro test
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Thermo Fischer Scientific Inc.
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Type benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Stallergenes Greer
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Type benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. HYCOR Biomedical
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Type benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Minaris Medical America, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Type benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Omega Diagnostics Ltd
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Type benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Lincoln Diagnostics, Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Type benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Danaher Corporation
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Type benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Alcon Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Type benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. AbbVie Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Type benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Sanofi
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Type benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Pfizer Inc.
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Type benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Merck & Co., Inc.
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Type benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. allergy diagnostics & therapeutics market, by type, 2018 - 2030 (USD Billion)
  • Table 3 U.S. allergy diagnostics & therapeutics market, by allergen type, 2018 - 2030 (USD Billion)
  • Table 4 U.S. allergy diagnostics & therapeutics market, by test type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. Allergy Diagnostics & Therapeutics market: market outlook
  • Fig. 10 U.S. Allergy Diagnostics & Therapeutics competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. Allergy Diagnostics & Therapeutics market driver impact
  • Fig. 16 U.S. Allergy Diagnostics & Therapeutics market restraint impact
  • Fig. 17 U.S. Allergy Diagnostics & Therapeutics market strategic initiatives analysis
  • Fig. 18 U.S. Allergy Diagnostics & Therapeutics market: type movement analysis
  • Fig. 19 U.S. Allergy Diagnostics & Therapeutics market: type outlook and key takeaways
  • Fig. 20 Diagnostics market estimates and forecast, 2018 - 2030
  • Fig. 21 Instrument market estimates and forecast, 2018 - 2030
  • Fig. 22 Consumable market estimates and forecast, 2018 - 2030
  • Fig. 23 Service market estimates and forecast, 2018 - 2030
  • Fig. 24 Therapeutics market estimates and forecast, 2018 - 2030
  • Fig. 25 Antihistamines market estimates and forecast, 2018 - 2030
  • Fig. 26 Decongestants market estimates and forecast, 2018 - 2030
  • Fig. 27 Corticosteroids market estimates and forecast, 2018 - 2030
  • Fig. 28 Mast cell stabilizers market estimates and forecast, 2018 - 2030
  • Fig. 29 Leukotriene inhibitors market estimates and forecast, 2018 - 2030
  • Fig. 30 Nasal anti - cholinergic market estimates and forecast, 2018 - 2030
  • Fig. 31 Immuno-modulators market estimates and forecast, 2018 - 2030
  • Fig. 32 Epinephrine market estimates and forecast, 2018 - 2030
  • Fig. 33 Immunotherapy market estimates and forecast, 2018 - 2030
  • Fig. 34 U.S. Allergy Diagnostics & Therapeutics market: allergen type movement analysis
  • Fig. 35 U.S. Allergy Diagnostics & Therapeutics market: allergen type outlook and key takeaways
  • Fig. 36 Food market estimates and forecasts, 2018 - 2030
  • Fig. 37 Dairy products market estimates and forecasts,2018 - 2030
  • Fig. 38 Poultry products market estimates and forecasts,2018- 2030
  • Fig. 39 Tree nuts market estimates and forecasts,2018 - 2030
  • Fig. 40 Peanuts market estimates and forecasts,2018 - 2030
  • Fig. 41 Shellfish market estimates and forecasts,2018 - 2030
  • Fig. 42 Soys market estimates and forecasts,2018 - 2030
  • Fig. 43 Other food allergens market estimates and forecasts,2018 - 2030
  • Fig. 44 Inhaled market estimates and forecasts,2018 - 2030
  • Fig. 45 Drug market estimates and forecasts,2018 - 2030
  • Fig. 46 Other allergens market estimates and forecasts,2018 - 2030
  • Fig. 47 U.S. Allergy Diagnostics & Therapeutics market: test type movement analysis
  • Fig. 48 U.S. Allergy Diagnostics & Therapeutics market: test type outlook and key takeaways
  • Fig. 49 North America market estimates and forecasts, 2018 - 2030
  • Fig. 50 In vivo test market estimates and forecasts, 2018 - 2030
  • Fig. 51 Skin prick test market estimates and forecasts, 2018 - 2030
  • Fig. 52 Intradermal market estimates and forecasts, 2018 - 2030
  • Fig. 53 Patch test market estimates and forecasts,2018 - 2030
  • Fig. 54 In vitro test market estimates and forecasts,2018 - 2030